169 related articles for article (PubMed ID: 34518930)
1. Late relapsing germ cell tumors with elevated tumor markers.
Che Y; Lusch A; Winter C; Große Siemer R; Buddensieck C; Albers P; Hiester A
World J Urol; 2022 Feb; 40(2):363-371. PubMed ID: 34518930
[TBL] [Abstract][Full Text] [Related]
2. Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-only.
Richardson NH; Althouse SK; Ashkar R; Cary C; Masterson T; Foster RS; Einhorn LH; Adra N
Clin Genitourin Cancer; 2023 Aug; 21(4):467-474. PubMed ID: 37088659
[TBL] [Abstract][Full Text] [Related]
3. Postchemotherapy Residual Tumor Resection in Patients with Elevated Tumor Markers.
Che Y; Buddensieck C; Albers P; Lusch A; Winter C; Siemer RG; Hiester A
J Urol; 2022 Mar; 207(3):617-626. PubMed ID: 34694152
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of late relapse on surveillance in patients presenting with clinical stage I testicular cancer.
Rice KR; Beck SD; Pedrosa JA; Masterson TA; Einhorn LH; Foster RS
Urology; 2014 Oct; 84(4):886-90. PubMed ID: 25260450
[TBL] [Abstract][Full Text] [Related]
5. Late relapse of germ cell tumors after cisplatin-based chemotherapy.
Gerl A; Clemm C; Schmeller N; Hentrich M; Lamerz R; Wilmanns W
Ann Oncol; 1997 Jan; 8(1):41-7. PubMed ID: 9093706
[TBL] [Abstract][Full Text] [Related]
6. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
Geldart TR; Gale J; McKendrick J; Kirby J; Mead G
BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677
[TBL] [Abstract][Full Text] [Related]
7. Pathologic findings and clinical outcomes in patients who required neoadjuvant chemotherapy before orchiectomy for testicular germ cell tumors.
Stump JA; Acosta AM; Whaley RD; Cheng L; Fang AM; Rais-Bahrami S; Gordetsky JB
Hum Pathol; 2022 Oct; 128():48-55. PubMed ID: 35817140
[TBL] [Abstract][Full Text] [Related]
8. Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor. Late results.
Loehrer PJ; Mandelbaum I; Hui S; Clark S; Einhorn LH; Williams SD; Donohue JP
J Thorac Cardiovasc Surg; 1986 Oct; 92(4):676-83. PubMed ID: 3020319
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
Schneider BP; Kesler KA; Brooks JA; Yiannoutsos C; Einhorn LH
J Clin Oncol; 2004 Apr; 22(7):1195-200. PubMed ID: 15051766
[TBL] [Abstract][Full Text] [Related]
10. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
Ronnen EA; Kondagunta GV; Bacik J; Marion S; Bajorin DF; Sheinfeld J; Bosl GJ; Motzer RJ
J Clin Oncol; 2005 Oct; 23(28):6999-7004. PubMed ID: 16192587
[TBL] [Abstract][Full Text] [Related]
11. [In which marker-positive patients with germ cell tumors is residual tumor resection of value?].
Weinknecht S; Hartmann M; Weissbach L
Urologe A; 1998 Nov; 37(6):621-4. PubMed ID: 9887490
[TBL] [Abstract][Full Text] [Related]
12. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Wood DP; Herr HW; Motzer RJ; Reuter V; Sogani PC; Morse MJ; Bosl GJ
Cancer; 1992 Nov; 70(9):2354-7. PubMed ID: 1382832
[TBL] [Abstract][Full Text] [Related]
13. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
14. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96.
Schneider DT; Wessalowski R; Calaminus G; Pape H; Bamberg M; Engert J; Waag K; Gadner H; Göbel U
J Clin Oncol; 2001 Apr; 19(7):1951-60. PubMed ID: 11283127
[TBL] [Abstract][Full Text] [Related]
16. Pattern of relapse after first line treatment of advanced stage germ-cell tumors.
Fléchon A; Culine S; Théodore C; Droz JP
Eur Urol; 2005 Dec; 48(6):957-63; discussion 963-4. PubMed ID: 16084010
[TBL] [Abstract][Full Text] [Related]
17. High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.
Lorch A; Rick O; Wündisch T; Hartmann JT; Bokemeyer C; Beyer J
J Urol; 2010 Jul; 184(1):168-73. PubMed ID: 20483152
[TBL] [Abstract][Full Text] [Related]
18. Management of primary malignant germ cell tumor of the mediastinum.
Sakurai H; Asamura H; Suzuki K; Watanabe S; Tsuchiya R
Jpn J Clin Oncol; 2004 Jul; 34(7):386-92. PubMed ID: 15342665
[TBL] [Abstract][Full Text] [Related]
19. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of the growing teratoma syndrome: A single-center experience and review of the literature.
Paffenholz P; Pfister D; Matveev V; Heidenreich A
Urol Oncol; 2018 Dec; 36(12):529.e23-529.e30. PubMed ID: 30446456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
